Bostal LLC
February 10, 2025
Plymouth
CNS/Neurological
.png)
Bostal LLC is an enabling platform technology pharmaceutical company. Established in New Jersey in 2004, Bostal expanded its global footprint, Bostal Drug Delivery, in China in 2013. With its long-acting injectable (LAI) platform technologies, including Zpheres® (microspheres), Geleepot® (in-situ gel), and nanosystems, Bostal has developed rich clinical stage pipelines of LAIs for GLP-1RAs and Schizophrenia. Lead products in Phase I studies approved by the US FDA include Semaglutide LAI (once monthly); Brexpiprazole LAI (once monthly); and BST-2227 LAI CNS (once bimonthly).
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}